Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Meier

Showing results (191-200 of 1,050) with videos related to

Pageof 105
Sort By:
American Politics Quarterly|January 1, 1987
Gaining ground: the impact of Medicaid and WIC on infant mortalityG W Copeland, K J Meier
JAMA|July 20, 1970
Intellectual changes associated with levodopa therapyM J Meier, W E Martin
European Journal of Clinical Pharmacology|October 4, 1974
Pharmacokinetic criteria for the evaluation of retard formulationsJ Meier, E Nüesch, R Schmidt
The Lancet. Diabetes & Endocrinology|December 15, 2016
Sitagliptin plus basal insulin: simplifying in-hospital diabetes treatment?Michael A Nauck, Juris J Meier
Pharmacogenetics|April 2, 2003
Pharmacogenetics of hepatocellular transportersChristiane Pauli-Magnus, Peter J Meier
Methods in Enzymology|January 1, 1990
Preparation of basolateral (sinusoidal) and canalicular plasma membrane vesicles for the study of hepatic transport processesP J Meier, J L Boyer
British Journal of Pharmacology|March 1, 1977
First-pass effect of the beta-adrenoceptor blocking agent pindolol in the dog [proceedings]J Meier, O Wagner, B Berde
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|January 1, 1997
[Social medicine in the ecology curriculum--Leipzig experiences with a social medicine practicum]J Meier, M Michel, S Riedel
Nature Reviews. Endocrinology|November 11, 2016
Diabetes: Incretin mimetics and insulin - closing the gap to normoglycaemiaMichael A Nauck, Juris J Meier
Toxicon : Official Journal of the International Society on Toxinology|January 1, 1988
Isoelectric focusing of Protac, the protein C activator from copperhead (Agkistrodon contortrix) venom: a note on experimental problemsJ Meier, C Adler, K Stocker
Pageof 105

Showing results (191-200 of 1,050) with videos related to

Sort By:
Pageof 105
American Politics Quarterly|January 1, 1987
Gaining ground: the impact of Medicaid and WIC on infant mortalityG W Copeland, K J Meier
JAMA|July 20, 1970
Intellectual changes associated with levodopa therapyM J Meier, W E Martin
European Journal of Clinical Pharmacology|October 4, 1974
Pharmacokinetic criteria for the evaluation of retard formulationsJ Meier, E Nüesch, R Schmidt
The Lancet. Diabetes & Endocrinology|December 15, 2016
Sitagliptin plus basal insulin: simplifying in-hospital diabetes treatment?Michael A Nauck, Juris J Meier
Pharmacogenetics|April 2, 2003
Pharmacogenetics of hepatocellular transportersChristiane Pauli-Magnus, Peter J Meier
Methods in Enzymology|January 1, 1990
Preparation of basolateral (sinusoidal) and canalicular plasma membrane vesicles for the study of hepatic transport processesP J Meier, J L Boyer
British Journal of Pharmacology|March 1, 1977
First-pass effect of the beta-adrenoceptor blocking agent pindolol in the dog [proceedings]J Meier, O Wagner, B Berde
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|January 1, 1997
[Social medicine in the ecology curriculum--Leipzig experiences with a social medicine practicum]J Meier, M Michel, S Riedel
Nature Reviews. Endocrinology|November 11, 2016
Diabetes: Incretin mimetics and insulin - closing the gap to normoglycaemiaMichael A Nauck, Juris J Meier
Toxicon : Official Journal of the International Society on Toxinology|January 1, 1988
Isoelectric focusing of Protac, the protein C activator from copperhead (Agkistrodon contortrix) venom: a note on experimental problemsJ Meier, C Adler, K Stocker
Pageof 105